Procept Biorobotics

Yahoo Finance • 24 days ago

Promising Growth Forecasts Leading to Analysts’ Optimism for Procept Biorobotics (PRCT)

Procept Biorobotics Corp. (NASDAQ:PRCT) is one of the most promising mid-cap healthcare stocks under $50. On December 12, UBS analyst Danielle Antalffy initiated coverage with a bullish rating on Procept Biorobotics Corp. (NASDAQ:PRCT). S... Full story

Yahoo Finance • 2 months ago

PROCEPT BioRobotics® to Present at Upcoming 37th Annual Piper Sandler Healthcare Conference on December 2, 2025

SAN JOSE, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that... Full story

Yahoo Finance • 2 months ago

Piper Sandler Reiterates a Buy on PROCEPT BioRobotics Corporation (PRCT)

​PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is one of the Fast-Growing Small Cap Stocks to Buy According to Analysts. On November 10, Matthew O’Brien from Piper Sandler reiterated a Buy rating on PROCEPT BioRobotics Corporation (NASDAQ:... Full story

Yahoo Finance • 2 months ago

PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance

SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today r... Full story

Yahoo Finance • 3 months ago

2 Robotics Stocks Riding the Sensor and Medical Boom

Key Points Robotics companies building enabling systems like sensors and LiDAR attracted $1.6 billion in 2025, as every robot needs vision capabilities. Medical robotics shows the clearest path from startup to profitability, with surgical... Full story

Yahoo Finance • 3 months ago

Is Procept BioRobotics Stock a Buy After Investment Company Chicago Capital Scoops Up Nearly 1 Million Shares?

Key Points Chicago Capital added 999,873 shares of Procept BioRobotics with an estimated purchase value of $45.65 million based on the average price for the quarter. The transaction represents a trade size equal to 1.12% of Chicago Capita... Full story

Yahoo Finance • 3 months ago

PROCEPT BioRobotics® to Report Third Quarter 2025 Financial Results on November 4, 2025

SAN JOSE, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today a... Full story

Yahoo Finance • 5 months ago

PROCEPT BioRobotics (PRCT) Outlook Adjusted as System Replacement Forecasts Shift

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) ranks among the top robotics to buy according to analysts. On August 7, Wells Fargo maintained its Overweight rating on PROCEPT BioRobotics Corporation (NASDAQ:PRCT) but reduced its price targe... Full story

Yahoo Finance • 5 months ago

Leerink Partners Reiterates a Buy Rating on PROCEPT BioRobotics (PRCT)

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is one of the best medical device stocks to buy according to analysts. On August 8, Leerink Partners analyst Mike Kratky reiterated a Buy rating on PROCEPT BioRobotics Corporation (NASDAQ:PRCT)... Full story

Yahoo Finance • 5 months ago

PROCEPT BioRobotics Corp. (NASDAQ:PRCT) Reports Q2 2025 Revenue Growth but Misses Profitability Targets, Triggering After-Hours Decline

PROCEPT BioRobotics Corp. (NASDAQ:PRCT [https://www.chartmill.com/stock/quote/PRCT]) reported its second-quarter 2025 financial results, delivering revenue growth but missing market expectations on profitability, leading to a sharp after-h... Full story

Yahoo Finance • 5 months ago

PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today r... Full story

Yahoo Finance • 6 months ago

PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO

Larry L. Wood to join PROCEPT BioRobotics effective September 2, 2025Company confirms strong underlying business trends and pre-announces 2Q25 revenue of approximately $79.2 million, representing annual growth of 48% SAN JOSE, Calif., Jul... Full story

Yahoo Finance • 6 months ago

PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025

SAN JOSE, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today a... Full story

Yahoo Finance • 6 months ago

Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule

SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through transformative urology solutions, today announce... Full story

Yahoo Finance • 7 months ago

PRCT shares drop 41% after InvestingPro's overvaluation warning proves accurate

When InvestingPro’s Fair Value models flagged (NASDAQ:PRCT) as significantly overvalued in November 2024, the stock was trading at $93.60. Seven months later, this bearish call has proven remarkably accurate, with shares dropping 41% to $5... Full story

Yahoo Finance • 9 months ago

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas

SAN JOSE, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company, whose mission is to revolutionize BPH treatment globally, announced today it will host an i... Full story

Yahoo Finance • 10 months ago

PROCEPT BioRobotics (PRCT): One of the Best Robotics Stocks to Buy According to Billionaires

We recently published a list of the 10 Best Robotics Stocks to Buy According to Billionaires. In this article, we are going to take a look at where PROCEPT BioRobotics Corporation (NASDAQ:PRCT) stands against the other robotics stocks held... Full story

Yahoo Finance • 10 months ago

WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser Enucleation

SAN JOSE, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through transformative urology solutions, today announc... Full story

Yahoo Finance • 10 months ago

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada

SAN JOSE, Calif., March 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announc... Full story

Yahoo Finance • 11 months ago

PROCEPT BioRobotics® Reports Fourth Quarter and Full Year 2024 Results

SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today re... Full story